Galmed Pharmaceuticals (GLMD) Non Operating Income (2013 - 2025)
Galmed Pharmaceuticals (GLMD) recorded quarterly Non Operating Income of $1.2 million in Q4 2025, up 712.81% quarter-over-quarter from -$203000.0 in Q3 2025, and up 47.74% on a YoY basis from $842000.0 in Q4 2024.
Galmed Pharmaceuticals (GLMD) Non Operating Income (2013 - 2025) Analysis & Trends
Galmed Pharmaceuticals' Non Operating Income history runs 12 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Non Operating Income rose 47.74% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $741000.0 (up 43.6% YoY), while the FY2025 annual figure was $741000.0, up 43.6% from the prior year.
- Non Operating Income was $1.2 million for Q4 2025 at Galmed Pharmaceuticals, up from -$203000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.2 million in Q4 2025 to a low of -$278000.0 in Q2 2023.
- Historically, Non Operating Income has averaged $140687.5 across 4 years, with a median of -$114500.0 in 2024.
- The sharpest annual moves came in 2021 and 2024: Non Operating Income surged 94.48% in 2021, then plunged 2040.0% in 2024.
- A 4-year view of Non Operating Income shows it stood at $788000.0 in 2021, then jumped by 30.08% to $1.0 million in 2023, then dropped by 17.85% to $842000.0 in 2024, then surged by 47.74% to $1.2 million in 2025.
- The last three Non Operating Income figures came in at $1.2 million (Q4 2025), -$203000.0 (Q3 2025), and -$140000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Galmed Pharmaceuticals | 2.48 Mn | -1.63 Mn | - | 1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | -203,000.00 |
| Jun 30, 2025 | -140,000.00 |
| Mar 31, 2025 | -160,000.00 |
| Dec 31, 2024 | 842,000.00 |
| Sep 30, 2024 | -97,000.00 |
| Jun 30, 2024 | -103,000.00 |
| Mar 31, 2024 | -126,000.00 |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | -278,000.00 |
| Mar 31, 2023 | -172,000.00 |
| Dec 31, 2021 | 788,000.00 |
| Sep 30, 2021 | -131,000.00 |
| Jun 30, 2021 | -16,000.00 |
| Mar 31, 2021 | -227,000.00 |
| Dec 31, 2020 | 2.81 Mn |
| Sep 30, 2020 | -685,000.00 |
| Jun 30, 2020 | -290,000.00 |
| Mar 31, 2020 | -399,000.00 |